nivolumab,bevacizumab,ipilimumab,celecoxib
roche,bms
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'niche', 'nivo', 'nivacor', 'crcsm', ' ipi ']
dr. le #asco22 #crcsm poster discussions: 1) phii nivacor trial addition of nivo to folfoxiri/bev in ras/braf mt adv crc (84% mss) orr of 76.7%, 2) final analysis of niche nivo x2 + ipi x1 6 wks prior to resectable #dmmr or #pmmr colon cancer 100% path responders in msi-h 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope